S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q4 2022

Deep Track Capital

Period: Q4 2022 Β· Filed: 2023-02-14
View on SEC EDGAR β†—
AUM
$2.38B
Total portfolio value
Positions
60
Reported securities
Top Holding
IMVT
7.2% $172.3M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
IMVTIMMUNOVANT INC$172.3M7.24%$18.75$38.79+106.9%
7.2%
ISEEIVERIC BIO INC$168.7M7.08%β€”β€”
7.1%
JAZZJAZZ PHARMACEUTICALS PLC$139.2M5.84%$156.36$243.47+55.7%
5.8%
TVTXTRAVERE THERAPEUTICS INC$96.4M4.05%$20.66$56.92+175.5%
4.0%
ASNDASCENDIS PHARMA A/S$85.5M3.59%$120.72$274.50+127.4%
3.6%
INSMINSMED INC$85.2M3.58%$19.18$111.60+481.9%
3.6%
BCYCBICYCLE THERAPEUTICS PLC$83.4M3.50%$30.00$4.35-85.5%
3.5%
VRNAVERONA PHARMA PLC$83.3M3.50%β€”β€”
3.5%
BIIBBIOGEN INC$83.1M3.49%$272.63$216.12-20.7%
3.5%
SWTXSPRINGWORKS THERAPEUTICS INC$80.9M3.40%β€”β€”
3.4%
KDNYCHINOOK THERAPEUTICS INC$78.6M3.30%β€”β€”
3.3%
SRPTSAREPTA THERAPEUTICS INC$68.5M2.87%$124.84$19.28-84.6%
2.9%
AGENAGENUS INC$64.8M2.72%$47.11$3.49-92.6%
2.7%
FDMT4D MOLECULAR THERAPEUTICS IN$59.0M2.48%$20.64$13.00-37.0%
2.5%
HZNPHORIZON THERAPEUTICS PUB L$56.9M2.39%β€”β€”
2.4%
HZNPPUTHORIZON THERAPEUTICS PUB L$56.9M2.39%β€”β€”
2.4%
DICEDICE THERAPEUTICS INC$54.1M2.27%β€”β€”
2.3%
VRDNVIRIDIAN THERAPEUTICS INC$51.7M2.17%$28.50$19.40-31.9%
2.2%
ETNB89BIO INC$49.0M2.06%β€”β€”
2.1%
BEAMBEAM THERAPEUTICS INC$45.6M1.92%$37.32$34.79-6.8%
1.9%
IONSIONIS PHARMACEUTICALS INC$45.5M1.91%$37.58$81.80+117.7%
1.9%
ALLKALLAKOS INC$41.3M1.73%β€”β€”
1.7%
RPTXREPARE THERAPEUTICS INC$40.1M1.68%β€”β€”
1.7%
ALBOALBIREO PHARMA INC$36.8M1.55%β€”β€”
1.6%
PLRXPLIANT THERAPEUTICS INC$33.5M1.41%$19.00$1.17-93.8%
1.4%
DYNDYNE THERAPEUTICS INC$31.1M1.31%$11.70$23.07+97.2%
1.3%
ASNDCALLASCENDIS PHARMA A/S$30.4M1.28%$120.72$274.50+127.4%
1.3%
EWTXEDGEWISE THERAPEUTICS INC$30.2M1.27%$8.79$39.56+350.1%
1.3%
SLNSILENCE THERAPEUTICS PLC$29.8M1.25%$14.69$10.39-29.3%
1.3%
AUTLAUTOLUS THERAPEUTICS PLC$28.5M1.20%$1.87$1.58-15.5%
1.2%

Quarter-on-Quarter Activity

Q4 2022 vs. Q3 2022

New Positions (8)

TickerIssuerNotionalSince Filing
INSMINSMED INC$85.2M+481.9%
BIIBBIOGEN INC$83.1M-20.7%
SRPTSAREPTA THERAPEUTICS INC$68.5M-84.6%
IONSIONIS PHARMACEUTICALS INC$45.5M+117.7%
AUTLAUTOLUS THERAPEUTICS PLC$28.5M-15.5%
ATXSASTRIA THERAPEUTICS INC$27.1M
RAPTRAPT THERAPEUTICS INC$25.8M
DVAXDYNAVAX TECHNOLOGIES CORP$24.8M

Exited Positions (8)

TickerIssuerNotional
NVCRNOVOCURE LTD$98.3M
KURAKURA ONCOLOGY INC$43.5M
FATEFATE THERAPEUTICS INC$29.4M
AKROAKERO THERAPEUTICS INC$26.9M
VERVVERVE THERAPEUTICS INC$26.6M
KALVKALVISTA PHARMACEUTICALS INC$26.5M
GBTGLOBAL BLOOD THERAPEUTICS IN$22.2M
FMTXFORMA THERAPEUTICS HLDGS INC$19.3M

Increased (8)

TickerIssuerNotionalShares Ξ”
RLMDRELMADA THERAPEUTICS INC$5.6M+2321.3%
RLMDRELMADA THERAPEUTICS INC$-7.2M+515.8%
ISEEIVERIC BIO INC$132.8M+293.9%
NTLAINTELLIA THERAPEUTICS INC$7.6M+133.3%
DICEDICE THERAPEUTICS INC$33.8M+73.4%
ALBOALBIREO PHARMA INC$15.3M+53.4%
ETNB89BIO INC$33.8M+46.1%
SWTXSPRINGWORKS THERAPEUTICS INC$13.3M+31.3%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
RETACALLREATA PHARMACEUTICALS INC$-7.5M-96.0%
AUPHAURINIA PHARMACEUTICALS INC$-41.3M-94.3%
HOOKHOOKIPA PHARMA INC$-5.7M-75.4%
ASNDCALLASCENDIS PHARMA A/S$-72.8M-75.1%+127.4%
BMRNBIOMARIN PHARMACEUTICAL INC$-43.0M-74.3%
ASNDCALLASCENDIS PHARMA A/S$-52.2M-68.8%+127.4%
HZNPPUTHORIZON THERAPEUTICS PUB L$-33.6M-65.8%
HZNPPUTHORIZON THERAPEUTICS PUB L$-33.6M-65.8%
← Back to Hedge Funds